Pentanoic acid, 5-(4-hydroxy-2,5-dimethylphenoxy)-2,2-dimethyl- | 80373-12-2

• 分子结构分类: 有机化合物 - 苯类化合物 - 酚类
• 英文名称: Pentanoic acid, 5-(4-hydroxy-2,5-dimethylphenoxy)-2,2-dimethyl-
• 英文别名: 5-(4-hydroxy-2,5-dimethylphenoxy)-2,2-dimethylpentanoic acid
• CAS: 80373-12-2
• 化学式: C₁₅H₂₂O₄
• 分子量: 266.33
• InChiKey: VJICDPYDJADQNH-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  3.4
• 重原子数：
  19
• 可旋转键数：
  6
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.53
• 拓扑面积：
  66.8
• 氢给体数：
  2
• 氢受体数：
  4

文献信息

• TERMINALIA FERDINANDIANA EXTRACT AND PRODUCTS CONTAINING EXTRACT OF TERMINALIA FERDINANDIANA FOR ANTIMICROBIAL OR ANTIBACTERIAL APPLICATIONS
  申请人：Rising Phoenix Industries Pty Ltd

  公开号：EP3618844A1

  公开（公告）日：2020-03-11
• US5166398A
  申请人：——

  公开号：US5166398A

  公开（公告）日：1992-11-24
• [EN] ANTIBACTERIAL COMBINATION THERAPY FOR THE TREATMENT OF GRAM POSITIVE BACTERIAL INFECTIONS<br/>[FR] POLYTHÉRAPIE ANTIBACTÉRIENNE POUR LE TRAITEMENT D'INFECTIONS BACTÉRIENNES
  申请人：E THERAPEUTICS PLC

  公开号：WO2009081117A1

  公开（公告）日：2009-07-02

  There is described a composition comprising a therapeutically active imidazole, or a derivative thereof, and gemfibrozil, or a derivative thereof. There is also described a method of treating a subject suffering from an infection using such a composition.
• [EN] BIOMARKERS OF REDUCED INSULIN ACTION<br/>[FR] MARQUEURS BIOLOGIQUES D'UNE ACTION RÉDUITE DE L'INSULINE
  申请人：MAYO FOUNDATION

  公开号：WO2012058298A1

  公开（公告）日：2012-05-03

  This document provides methods and materials for assessing metabolic disorders related to reduced insulin action (e.g. insulin resistance or insulin deficiency) in a mammal (e.g. human). For example, methods and materials for assessing insulin resistance, risk of developing insulin resistance and monitoring efficacy of insulin resistance treatment are provided.
• [EN] TREATMENT OR PREVENTION OF GIARDIASIS WITH A BIOLOGICALLY ACTIVE EXTRACT FROM TERMINALIA FERDINANDIANA FRUIT<br/>[FR] TRAITEMENT OU PRÉVENTION DE LA GIARDIASE COMPRENANT UN EXTRAIT BIOLOGIQUEMENT ACTIF PROVENANT DU FRUIT DE TERMINALIA FERDINANDIANA
  申请人：GUNAGUDDYA PTY LTD

  公开号：WO2017063017A1

  公开（公告）日：2017-04-20

  Method and use and of an extracted plant based compound of genus Terminalia (particularly, T. ferdinandiana ) in the preparation of a medicament which inhibits and/or blocks the growth of gastrointestinal parasites of the genus Giardia (particularly, G. duodenalis) in humans, animals and as a treatment for potable water. For the current study method and use and of a plant derivative (where these chemical compounds which are commercially obtained) as extract of genus Terminalia (particularly, T. ferdinandiana ) in the preparation of a medicament which inhibits and/or blocks the growth of gastrointestinal parasites of the genus Giardia (particularly, G. duodenalis) in humans, animals and as a treatment for potable water and / or as a pharmaceutical or nutraceutical supplement.